Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating Activities    
Net loss $ (1,932) $ (2,372)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 406 443
Write-down of inventory 311 557
Deferred income taxes 784 7
Non-cash share-based compensation expense 68 169
Loss on sale of subsidiary 2,793  
(Reversal of) provision for allowance for doubtful accounts, net (59) 44
Other, net 13 106
Changes in operating assets and liabilities:    
Accounts receivable 3,296 (2,568)
Inventories 1,025 228
Other assets (1,458) 7,939
Accounts payable (1,983) 520
Accrued income taxes (1,616) 831
Accrued and other liabilities (486) (684)
Contract liabilities (1,330) (5,866)
Net cash used in operating activities (168) (646)
Investing Activities    
Purchases of property, plant and equipment (173) (152)
Net cash disposed of in sale of subsidiary (647)  
Net cash used in investing activities (820) (152)
Financing Activities    
Proceeds from the exercise of stock options 701 37
Payments on long-term debt (103) (95)
Net cash provided by (used in) financing activities 598 (58)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 1,141 (662)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 751 (1,518)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period [1] 59,134 62,496
Cash, Cash Equivalents and Restricted Cash, End of Period [1] $ 59,885 $ 60,978
[1] Includes Cash, Cash Equivalents and Restricted Cash that are included in Held-For-Sale Assets on the Condensed Consolidated Balance Sheets.